Marks & Spencer Group plc buy krebskrebs
Start price
29.06.20
/
50%
€1.13
Target price
04.11.21
€1.40
Performance (%)
99.82%
End price
05.11.21
€2.26
Summary
This prediction ended on 05.11.21 with a price of €2.26. The BUY prediction by krebskrebs for Marks & Spencer Group plc saw massive gains of 99.82%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marks & Spencer Group plc | 7.143% | 7.143% | 19.940% | 98.593% |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% | 53.464% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% | 72.276% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% | 63.079% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% | 60.400% |
Comments by krebskrebs for this prediction
In the thread Marks & Spencer Group plc diskutieren
Buy mit Kursziel 1,4
In the thread Trading Marks & Spencer Group plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

